Deutsche Bank’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q1 | – | Sell |
-7
| Closed | – | – | 4678 |
|
2019
Q4 | $0 | Hold |
7
| – | – | ﹤0.01% | 4864 |
|
2019
Q3 | $0 | Sell |
7
-1,769
| -100% | – | ﹤0.01% | 4941 |
|
2019
Q2 | $11K | Buy |
1,776
+1,669
| +1,560% | +$10.3K | ﹤0.01% | 4580 |
|
2019
Q1 | $1K | Buy |
107
+91
| +569% | +$850 | ﹤0.01% | 4694 |
|
2018
Q4 | $0 | Sell |
16
-2,201
| -99% | – | ﹤0.01% | 4952 |
|
2018
Q3 | $43K | Sell |
2,217
-7,785
| -78% | -$151K | ﹤0.01% | 4493 |
|
2018
Q2 | $181K | Sell |
10,002
-129,994
| -93% | -$2.35M | ﹤0.01% | 4198 |
|
2018
Q1 | $1.49M | Buy |
139,996
+71,405
| +104% | +$759K | ﹤0.01% | 3043 |
|
2017
Q4 | $2.89M | Buy |
68,591
+4,485
| +7% | +$189K | ﹤0.01% | 2456 |
|
2017
Q3 | $3.53M | Buy |
64,106
+51,145
| +395% | +$2.81M | ﹤0.01% | 2120 |
|
2017
Q2 | $2.4M | Buy |
12,961
+12,141
| +1,481% | +$2.25M | ﹤0.01% | 2416 |
|
2017
Q1 | $96K | Sell |
820
-1,005
| -55% | -$118K | ﹤0.01% | 3736 |
|
2016
Q4 | $180K | Sell |
1,825
-3,503
| -66% | -$346K | ﹤0.01% | 3582 |
|
2016
Q3 | $596K | Buy |
5,328
+4,174
| +362% | +$467K | ﹤0.01% | 3040 |
|
2016
Q2 | $117K | Buy |
1,154
+882
| +324% | +$89.4K | ﹤0.01% | 3864 |
|
2016
Q1 | $24K | Sell |
272
-17,001
| -98% | -$1.5M | ﹤0.01% | 4283 |
|
2015
Q4 | $2.49M | Buy |
17,273
+16,784
| +3,432% | +$2.42M | ﹤0.01% | 2269 |
|
2015
Q3 | $50K | Buy |
+489
| New | +$50K | ﹤0.01% | 4160 |
|